➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
Johnson and Johnson
McKinsey
Moodys

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

BOTOX Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Litigation for BOTOX

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
In re: Aoki2013-07-30

See all BOTOX litigation

PTAB Litigation
PetitionerDate
2017-02-21

See all BOTOX litigation

Pharmacology for BOTOX

Company Disclosures: US Patents for BOTOX

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial The Regents of the University of Colorado (Boulder, CO) 2017-07-15 RX company
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2013-12-28 RX company
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2013-12-28 RX company
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2013-12-28 RX company
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial The Regents of the University of Colorado (Boulder, CO) 2017-07-15 RX company
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial The Regents of the University of Colorado (Boulder, CO) 2017-07-15 RX company
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial The Regents of the University of Colorado (Denver, CO) 2017-07-15 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for BOTOX

These patents were identified by searching patent claims

Supplementary Protection Certificates for BOTOX

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
132008901655480 Italy   Start Trial PRODUCT NAME: NEUROTOSSINA DI CLOSTRIDIUM BOTULINUM DI TIPO A (150 KD) PRIVA DI PROTEINE COMPLESSATE(XEOMIN); AUTHORISATION NUMBER(S) AND DATE(S): 838, 20080409;57093.00.00, 20050531
C300564 Netherlands   Start Trial PRODUCT NAME: BOTULINUM TOXINE; NAT. REGISTRATION NO/DATE: RVG 32957RVG 17379RVG 32958 2012270627; FIRST REGISTRATION: NL 25449 20110822
CR 2013 00041 Denmark   Start Trial PRODUCT NAME: BOTULINUM TOXIN, HERUNDER BOTULINUM TOXIN A; NAT. REG. NO/DATE: 43623, 31350, 46039 (DK) 20130219; FIRST REG. NO/DATE: FI 25162,15424, 28146 20130116
300563 Netherlands   Start Trial DETAILS ASSIGNMENT: VERANDERING VAN EIGENAAR(S), OVERDRACHT
SPC/GB12/053 United Kingdom   Start Trial PRODUCT NAME: BOTULINUM TOXIN; REGISTERED: UK PL 00426/0074-0110 20120924; UK PL 00426/0118-0030 20120924; UK PL 00426/0119-0012 20120924; REASON FOR LAPSE: SURRENDERED
C300654 Netherlands   Start Trial PRODUCT NAME: BOTULINUM TOXINE, TYPE A; NAT. REGISTRATION NO/DATE: RVG 17379RVG 32957RVG 32958 20131029; FIRST REGISTRATION:
122008000043 Germany   Start Trial PRODUCT NAME: CLOSTRIDIUM BOTULINUM NEUROTOXIN TYP A (150KD), FREI VON KOMPLEXPROTEINEN; REGISTRATION NO/DATE: 57093.00.00 20050531
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Colorcon
AstraZeneca
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.